Main Article Content

Abstract

Background: The rising frequency of chronic kidney failure poses a significant worldwide health concern. Patients afflicted with chronic kidney failure experience increased rates of morbidity and mortality. A significant proportion of people afflicted with chronic renal failure had an infection during the later stages of their illness, leading to inefficient treatment, great financial strain, and noteworthy negative effects on their emotional, financial, and general well-being.
Objective: The objective of this study was to describe the total cost of therapy in patients with chronic kidney failure and to find out the relationship between these characteristics and the cost of therapy.
Method: This research is a pharmacoeconomic study using a provider perspective and a societal perspective with an observational descriptive design. The sample in this study was 75 with a non-random sample determination purposive sampling method.
Results: Based on the results of this study, the average total cost of therapy for chronic kidney failure patients is Rp. 5,118,274.72. The biggest total cost is the cost of lost productivity, which is Rp. 1,637,728.72 (32.00%). The highest direct medical cost is the cost of hemodialysis (37.35%), while the highest direct non-medical cost is the cost of eating (68.03%).
Conclusion: The average cost of total therapy is Rp. 5,118,274.72, and there are characteristics that have a relationship to the cost of therapy, namely the degree of severity (p-value 0.01) and length of illness (p-value 0.033).
Keywords: Chronic kidney disease; cost of illness; pharmacoeconomics


Intisari
Latar belakang: Meningkatnya frekuensi gagal ginjal kronik menimbulkan masalah kesehatan yang signifikan di seluruh dunia. Pasien gagal ginjal kronik mengalami peningkatan angka kesakitan dan kematian. Sejumlah besar orang yang menderita gagal ginjal kronis mengalami infeksi pada tahap akhir penyakitnya, sehingga menyebabkan pengobatan yang tidak efisien, tekanan keuangan yang besar, dan dampak negatif yang patut dicatat terhadap emosi, keuangan, dan kesejahteraan umum mereka.
Metode: Penelitian ini merupakan penelitian farmakoekonomi menggunakan perspektif provider dan societal dengan desain deskriptif observasional. Sampel penelitian ini berjumlah 75 orang melalui non-random sampling dengan menggunakan purposive sampling.
Hasil: Berdasarkan hasil penelitian, total rata-rata biaya pengobatan pasien gagal ginjal kronis adalah Rp. 5.118.274,72. Total biaya terbesar adalah biaya pengobatan langsung (44,46%). Adapun biaya pengobatan tidak langsung sebesar 23,54% dan biaya hilangnya produktivitas senilai 32%.
Kesimpulan: Biaya rata-rata terapi total yaitu sebesar Rp. 5.118.274,7; dan karakteristik pasien yang memiliki hubungan terhadap biaya terapi yaitu derajat keparhan p-value 0,019 dan lama penyakit p-value 0,033.
Kata kunci: Gagal ginjal kronis, cost of illness, farmakoekonomi

Keywords

chronic kidney disease cost of illness pharmacoeconomics

Article Details

References

Read More